Mannkind (MNKD) Other financing activities (2013 - 2025)
Mannkind's (MNKD) quarterly Other financing activities came in at $4.9 million in Q4 2025, down 96.56% on a QoQ basis from $143.1 million in Q4 2023.
Mannkind (MNKD) Other financing activities (2013 - 2025) Analysis & Trends
Mannkind (MNKD) has 10 years of Other financing activities data on file, last reported at $4.9 million in Q4 2025.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $4.9 million in Q4 2025; TTM through Dec 2025 was $153.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.3 million, changed N/A from the prior year.
- Other financing activities for Q4 2025 stood at $4.9 million, down from $143.1 million in the prior quarter.
- Over the last five years, Other financing activities for MNKD reached as high as $143.1 million in Q4 2023 and fell as low as $100000.0 in Q2 2021.
- Historically, Other financing activities has averaged $19.6 million across 4 years, with a median of $1.8 million in 2021.
- Across the five-year window, Other financing activities jumped 969.76% in 2022 and jumped 75.15% in 2023, its largest moves.
- Year by year, Other financing activities stood at $1.8 million in 2021, then soared by 969.76% to $19.1 million in 2022, then soared by 649.05% to $143.1 million in 2023, then sank by 96.56% to $4.9 million in 2025.
- Per Business Quant data, the three most recent Other financing activities figures were $4.9 million in Q4 2025, $143.1 million in Q4 2023, and $4.1 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Mannkind | 1.26 Bn | 1.13 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.92 Mn |
| Dec 31, 2025 | 4.92 Mn |
| Dec 31, 2023 | 143.11 Mn |
| Dec 31, 2023 | 143.11 Mn |
| Sep 30, 2023 | 4.11 Mn |
| Sep 30, 2023 | 4.11 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 19.11 Mn |
| Dec 31, 2022 | 19.11 Mn |
| Mar 31, 2022 | 684,000.00 |
| Mar 31, 2022 | 684,000.00 |
| Dec 31, 2021 | 1.79 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Jun 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Jun 30, 2020 | -654,000.00 |
| Jun 30, 2020 | -654,000.00 |